Pick Up This Bargain Even Cheaper Than Director Goldberg Did

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on November 6, ImmunoGen, Inc.'s Director, Mark Alan Goldberg, invested $172,800.00 into 30,000 shares of IMGN, for a cost per share of $5.76..